Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Peter F. Hahn, M.D., Ph.D.

Co-Author

This page shows the publications co-authored by Peter Hahn and Sanjay Saini.
Connection Strength

3.455
  1. Evaluation of simethicone coated cellulose (SonoRx) as a negative oral contrast agent for abdominal-pelvic computed tomography. Acad Radiol. 2002 Aug; 9 Suppl 2:S357-8.
    View in: PubMed
    Score: 0.264
  2. Liver-specific MR imaging contrast agents. Radiol Clin North Am. 1998 Mar; 36(2):287-97.
    View in: PubMed
    Score: 0.194
  3. Clinical evaluation of ultrasmall superparamagnetic iron oxide particles for liver imaging. Acad Radiol. 1996 Aug; 3 Suppl 2:S409-12.
    View in: PubMed
    Score: 0.174
  4. Distinguishing hemangiomas from metastases on liver MRI performed with gadoxetate disodium: Value of the extended washout sign. Eur J Radiol. 2016 Mar; 85(3):635-40.
    View in: PubMed
    Score: 0.167
  5. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227). AJR Am J Roentgenol. 1995 May; 164(5):1147-52.
    View in: PubMed
    Score: 0.160
  6. 16-MDCT angiography in living kidney donors at various tube potentials: impact on image quality and radiation dose. AJR Am J Roentgenol. 2007 Jan; 188(1):115-20.
    View in: PubMed
    Score: 0.090
  7. Using the K-edge to improve contrast conspicuity and to lower radiation dose with a 16-MDCT: a phantom and human study. J Comput Assist Tomogr. 2006 May-Jun; 30(3):391-7.
    View in: PubMed
    Score: 0.086
  8. Distinguishing hepatic metastases from hemangiomas: qualitative and quantitative diagnostic performance through dual echo respiratory-triggered fast spin echo magnetic resonance imaging. J Comput Assist Tomogr. 2005 Sep-Oct; 29(5):571-9.
    View in: PubMed
    Score: 0.082
  9. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET. AJR Am J Roentgenol. 2005 Jul; 185(1):239-46.
    View in: PubMed
    Score: 0.081
  10. Detection of liver metastases from gastrointestinal cancer: comparision of high resolution MnDPDP enhanced MRI and FDG-PET. Acad Radiol. 2005 May; 12 Suppl 1:S17-20.
    View in: PubMed
    Score: 0.080
  11. Low-dose CT of the abdomen: evaluation of image improvement with use of noise reduction filters pilot study. Radiology. 2003 Jul; 228(1):251-6.
    View in: PubMed
    Score: 0.070
  12. Intraductal papillary mucinous tumors of the pancreas. Abdom Imaging. 2003 May-Jun; 28(3):357-65.
    View in: PubMed
    Score: 0.070
  13. Evaluation of simethicone-coated cellulose as a negative oral contrast agent for abdominal CT. Acad Radiol. 2003 May; 10(5):491-6.
    View in: PubMed
    Score: 0.070
  14. Thorotrast-induced cholangiocarcinoma: case report. Abdom Imaging. 2003 Jan-Feb; 28(1):72-4.
    View in: PubMed
    Score: 0.068
  15. Liver lesion detection and characterization with sequential use of hepatobiliary contrast agent mangafodipir trisodium and gadolinium-DTPA in a single imaging protocol. Acad Radiol. 2002 Aug; 9 Suppl 2:S460-2.
    View in: PubMed
    Score: 0.066
  16. Contrast-enhanced MRI of the liver with mangafodipir trisodium: imaging technique and results. J Comput Assist Tomogr. 2002 Mar-Apr; 26(2):216-22.
    View in: PubMed
    Score: 0.064
  17. Functioning acinar cell pancreatic carcinoma: diagnosis on mangafodipir trisodium (Mn-DPDP)-enhanced MRI. J Comput Assist Tomogr. 2002 Jan-Feb; 26(1):126-8.
    View in: PubMed
    Score: 0.063
  18. Splenic imaging with ultrasmall superparamagnetic iron oxide ferumoxtran-10 (AMI-7227): preliminary observations. J Comput Assist Tomogr. 2001 Sep-Oct; 25(5):770-6.
    View in: PubMed
    Score: 0.062
  19. Dynamic T1-weighted ferumoxides enhanced MRI for imaging liver hemangiomas: preliminary observations. Abdom Imaging. 2001 Mar-Apr; 26(2):166-70.
    View in: PubMed
    Score: 0.060
  20. Multicentre dose-ranging study on the efficacy of USPIO ferumoxtran-10 for liver MR imaging. Clin Radiol. 2000 Sep; 55(9):690-5.
    View in: PubMed
    Score: 0.058
  21. Abdominal Imaging Findings in COVID-19: Preliminary Observations. Radiology. 2020 10; 297(1):E207-E215.
    View in: PubMed
    Score: 0.057
  22. Addition of gadolinium chelates to heavily T2-weighted MR imaging: limited role in differentiating hepatic hemangiomas from metastases. AJR Am J Roentgenol. 2000 Feb; 174(2):477-85.
    View in: PubMed
    Score: 0.056
  23. MR imaging of the liver with Gd-BOPTA: quantitative analysis of T1-weighted images at two different doses. J Magn Reson Imaging. 1999 Jul; 10(1):80-3.
    View in: PubMed
    Score: 0.053
  24. Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227. Radiology. 1997 Mar; 202(3):687-91.
    View in: PubMed
    Score: 0.045
  25. Contrast-enhanced MR imaging of the liver: comparison between Gd-BOPTA and Mangafodipir. J Magn Reson Imaging. 1997 Jan-Feb; 7(1):130-5.
    View in: PubMed
    Score: 0.045
  26. Mn-DPDP enhanced MR imaging of the liver: analysis of pulse sequence performance. Clin Radiol. 1996 Jul; 51(7):484-6.
    View in: PubMed
    Score: 0.043
  27. MR contrast material for vascular enhancement: value of superparamagnetic iron oxide. AJR Am J Roentgenol. 1996 Jan; 166(1):73-7.
    View in: PubMed
    Score: 0.042
  28. Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures. AJR Am J Roentgenol. 1995 Jul; 165(1):91-5.
    View in: PubMed
    Score: 0.040
  29. Echoplanar MR imaging of the liver in patients with focal hepatic lesions: quantitative analysis of images made with various pulse sequences. AJR Am J Roentgenol. 1994 Dec; 163(6):1389-93.
    View in: PubMed
    Score: 0.039
  30. Palliation of malignant bile duct obstruction with metallic biliary endoprostheses: technique, results, and complications. J Vasc Interv Radiol. 1992 Nov; 3(4):665-71.
    View in: PubMed
    Score: 0.034
  31. An aqueous gastrointestinal contrast agent for use in echo-planar MR imaging. Magn Reson Med. 1992 Jun; 25(2):380-3.
    View in: PubMed
    Score: 0.033
  32. Sclerotherapy of malignant pleural effusion through sonographically placed small-bore catheters. AJR Am J Roentgenol. 1992 Jan; 158(1):41-3.
    View in: PubMed
    Score: 0.032
  33. MR imaging of liver metastases at 1.5 T: similar contrast discrimination with T1- and T2-weighted pulse sequences. Radiology. 1991 Nov; 181(2):449-53.
    View in: PubMed
    Score: 0.031
  34. Occlusion of biliary endoprostheses: presentation and management. Radiology. 1990 Aug; 176(2):531-4.
    View in: PubMed
    Score: 0.029
  35. First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging. Radiology. 1990 Jun; 175(3):695-700.
    View in: PubMed
    Score: 0.028
  36. Percutaneous gastrostomy with gastropexy: experience in 125 patients. AJR Am J Roentgenol. 1990 May; 154(5):1003-6.
    View in: PubMed
    Score: 0.028
  37. The differential diagnosis of ringed hepatic lesions in MR imaging. AJR Am J Roentgenol. 1990 Feb; 154(2):287-90.
    View in: PubMed
    Score: 0.028
  38. Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors. Radiology. 1990 Feb; 174(2):361-6.
    View in: PubMed
    Score: 0.028
  39. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics. 2009 Oct; 29(6):1725-48.
    View in: PubMed
    Score: 0.027
  40. Forty-millisecond MR imaging of the abdomen at 2.0 T. Radiology. 1989 Oct; 173(1):111-6.
    View in: PubMed
    Score: 0.027
  41. New universal precaution aspiration tray. Radiology. 1989 Oct; 173(1):278-9.
    View in: PubMed
    Score: 0.027
  42. MR imaging of focal splenic tumors. AJR Am J Roentgenol. 1988 Apr; 150(4):823-7.
    View in: PubMed
    Score: 0.024
  43. Effect of obesity on image quality: fifteen-year longitudinal study for evaluation of dictated radiology reports. Radiology. 2006 Aug; 240(2):435-9.
    View in: PubMed
    Score: 0.022
  44. Imaging diagnosis of cystic pancreatic lesions: pseudocyst versus nonpseudocyst. Radiographics. 2005 May-Jun; 25(3):671-85.
    View in: PubMed
    Score: 0.020
  45. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology. 2005 Mar; 234(3):785-92.
    View in: PubMed
    Score: 0.020
  46. Multidetector-row computed tomography angiography for planning intra-arterial chemotherapy pump placement in patients with colorectal metastases to the liver. J Comput Assist Tomogr. 2004 Jul-Aug; 28(4):478-84.
    View in: PubMed
    Score: 0.019
  47. Radiological measurement of breast cancer metastases to lung and liver: comparison between WHO (bidimensional) and RECIST (unidimensional) guidelines. J Comput Assist Tomogr. 2003 May-Jun; 27(3):380-4.
    View in: PubMed
    Score: 0.017
  48. CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations. Radiology. 2002 Nov; 225(2):416-9.
    View in: PubMed
    Score: 0.017
  49. CT characterization of "indeterminate" renal masses: targeted or comprehensive scanning? J Comput Assist Tomogr. 2002 Sep-Oct; 26(5):725-7.
    View in: PubMed
    Score: 0.017
  50. MR lymphangiography for detection of minimal nodal disease in patients with prostate cancer. Acad Radiol. 2002 Aug; 9 Suppl 2:S312-3.
    View in: PubMed
    Score: 0.016
  51. Using multidetector CT for preoperative vascular evaluation of liver neoplasms: technique and results. AJR Am J Roentgenol. 2002 Jul; 179(1):53-9.
    View in: PubMed
    Score: 0.016
  52. Characterizing liver hemangiomas on ferumoxides-enhanced dynamic TI-weighted imaging: preliminary experience. Acad Radiol. 2002 May; 9 Suppl 1:S255-6.
    View in: PubMed
    Score: 0.016
  53. Comprehensive evaluation of patients with haematuria on multi-slice computed tomography scanner: protocol design and preliminary observations. Australas Radiol. 2001 Nov; 45(4):536-8.
    View in: PubMed
    Score: 0.016
  54. MRI contrast agents for evaluating focal hepatic lesions. Clin Radiol. 2001 Sep; 56(9):714-25.
    View in: PubMed
    Score: 0.015
  55. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization. Clin Radiol. 2001 May; 56(5):410-5.
    View in: PubMed
    Score: 0.015
  56. Comparison of in-phase and out-of-phase gradient recalled echo T1-weighted pulse sequence for MR imaging of malignant liver masses following administration of paramagnetic gadolinium-chelate. Abdom Imaging. 2000 Mar-Apr; 25(2):159-63.
    View in: PubMed
    Score: 0.014
  57. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation. AJR Am J Roentgenol. 1999 May; 172(5):1347-51.
    View in: PubMed
    Score: 0.013
  58. Safety profile of ultrasmall superparamagnetic iron oxide ferumoxtran-10: phase II clinical trial data. J Magn Reson Imaging. 1999 Feb; 9(2):291-4.
    View in: PubMed
    Score: 0.013
  59. MR imaging of lymph nodes in patients with primary abdominal and pelvic malignancies using ultrasmall superparamagnetic iron oxide (Combidex). Acad Radiol. 1998 Apr; 5 Suppl 1:S167-9, discussion S183-4.
    View in: PubMed
    Score: 0.012
  60. US-guided thoracentesis: requirement for postprocedure chest radiography in patients who receive mechanical ventilation versus patients who breathe spontaneously. Radiology. 1997 Aug; 204(2):503-6.
    View in: PubMed
    Score: 0.012
  61. Percutaneous gastrostomy with T-fastener gastropexy: results of 316 consecutive procedures. Radiology. 1997 May; 203(2):496-500.
    View in: PubMed
    Score: 0.011
  62. Focal liver lesions: characterization with conventional spin-echo versus fast spin-echo T2-weighted MR imaging. Radiology. 1997 Feb; 202(2):389-93.
    View in: PubMed
    Score: 0.011
  63. Gadolinium-DTPA enhanced echoplanar MR imaging of the liver: preliminary observations. Clin Radiol. 1996 Aug; 51(8):545-9.
    View in: PubMed
    Score: 0.011
  64. Failed metallic biliary stents: causes and management of delayed complications. Clin Radiol. 1994 Dec; 49(12):857-62.
    View in: PubMed
    Score: 0.010
  65. Hepatic hemangiomas and malignant tumors: improved differentiation with heavily T2-weighted conventional spin-echo MR imaging. Radiology. 1994 Oct; 193(1):43-7.
    View in: PubMed
    Score: 0.010
  66. Clinical application of abdominal echoplanar imaging (EPI): optimization using a retrofitted EPI system. J Comput Assist Tomogr. 1994 Sep-Oct; 18(5):673-9.
    View in: PubMed
    Score: 0.010
  67. State-of-the-art MR imaging of the adrenal gland. Radiographics. 1994 Sep; 14(5):1015-29; discussion 1029-32.
    View in: PubMed
    Score: 0.010
  68. MR imaging of the liver at 1.5 T: value of signal averaging in suppressing motion artifacts. AJR Am J Roentgenol. 1994 Aug; 163(2):335-7.
    View in: PubMed
    Score: 0.009
  69. T2-weighted MR imaging of the upper part of the abdomen: should fat suppression be used routinely? AJR Am J Roentgenol. 1994 May; 162(5):1095-100.
    View in: PubMed
    Score: 0.009
  70. Percutaneous management of hilar biliary malignancies with metallic endoprostheses: results, technical problems, and causes of failure. Radiographics. 1993 Nov; 13(6):1249-63.
    View in: PubMed
    Score: 0.009
  71. Value of T1 and T2 relaxation times from echoplanar MR imaging in the characterization of focal hepatic lesions. AJR Am J Roentgenol. 1993 May; 160(5):1011-7.
    View in: PubMed
    Score: 0.009
  72. MR angiography of the portal and hepatic venous systems: preliminary experience with echoplanar imaging. AJR Am J Roentgenol. 1993 Jan; 160(1):35-40.
    View in: PubMed
    Score: 0.008
  73. Differential diagnosis of hyperintense liver lesions on T1-weighted MR images. AJR Am J Roentgenol. 1992 Nov; 159(5):1017-20.
    View in: PubMed
    Score: 0.008
  74. Measurement of tissue carcinoembryonic antigen levels from fine-needle biopsy specimens: technique and clinical usefulness. Radiology. 1992 Sep; 184(3):717-20.
    View in: PubMed
    Score: 0.008
  75. Wallstent metallic biliary endoprosthesis: MR imaging characteristics. Radiology. 1992 Sep; 184(3):874-6.
    View in: PubMed
    Score: 0.008
  76. Acute complicated pancreatitis: redefining the role of interventional radiology. Radiology. 1992 Apr; 183(1):171-4.
    View in: PubMed
    Score: 0.008
  77. Techniques for high-resolution echo-planar MR imaging of the pancreas. Radiology. 1992 Jan; 182(1):175-9.
    View in: PubMed
    Score: 0.008
  78. Percutaneous dilatation of benign biliary strictures: single-session therapy with general anesthesia. AJR Am J Roentgenol. 1991 Dec; 157(6):1263-6.
    View in: PubMed
    Score: 0.008
  79. Malignant small bowel obstruction and ascites: not a contraindication to percutaneous gastrostomy. Clin Radiol. 1991 Nov; 44(5):332-4.
    View in: PubMed
    Score: 0.008
  80. Differentiation between hemangiomas and metastases of the liver with ultrafast MR imaging: preliminary results with T2 calculations. AJR Am J Roentgenol. 1991 Oct; 157(4):727-30.
    View in: PubMed
    Score: 0.008
  81. Percutaneous contact dissolution of gallstones: complexity of radiologic care. Radiographics. 1991 Sep; 11(5):759-70.
    View in: PubMed
    Score: 0.008
  82. Importance of daily rounds by the radiologist after interventional procedures of the abdomen and chest. Radiology. 1991 Sep; 180(3):767-70.
    View in: PubMed
    Score: 0.008
  83. Treatment of critically ill patients with sepsis of unknown cause: value of percutaneous cholecystostomy. AJR Am J Roentgenol. 1991 Jun; 156(6):1163-6.
    View in: PubMed
    Score: 0.008
  84. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology. 1991 May; 179(2):415-8.
    View in: PubMed
    Score: 0.008
  85. Focal nodular hyperplasia of the liver: MR findings in 35 proved cases. AJR Am J Roentgenol. 1991 Feb; 156(2):317-20.
    View in: PubMed
    Score: 0.007
  86. Differentiation between small hepatic hemangiomas and metastases on MR images: importance of size-specific quantitative criteria. AJR Am J Roentgenol. 1990 Jul; 155(1):61-6.
    View in: PubMed
    Score: 0.007
  87. Infected abdominal tumors: percutaneous catheter drainage. Radiology. 1989 Dec; 173(3):627-9.
    View in: PubMed
    Score: 0.007
  88. Central scars in primary liver tumors: MR features, specificity, and pathologic correlation. Radiology. 1989 May; 171(2):323-6.
    View in: PubMed
    Score: 0.007
  89. Short TI inversion-recovery imaging of the liver: pulse-sequence optimization and comparison with spin-echo imaging. Radiology. 1989 May; 171(2):327-33.
    View in: PubMed
    Score: 0.007
  90. Imaging of pancreatic neoplasms: comparison of MR and CT. AJR Am J Roentgenol. 1989 Mar; 152(3):487-91.
    View in: PubMed
    Score: 0.007
  91. MR imaging of liver neoplasms. AJR Am J Roentgenol. 1989 Mar; 152(3):493-9.
    View in: PubMed
    Score: 0.007
  92. The sonographic diagnosis of acute gangrenous cholecystitis: importance of the Murphy sign. AJR Am J Roentgenol. 1989 Feb; 152(2):289-90.
    View in: PubMed
    Score: 0.006
  93. Clinical use of a nonferromagnetic needle for magnetic resonance-guided biopsy. Gastrointest Radiol. 1989; 14(1):61-4.
    View in: PubMed
    Score: 0.006
  94. The diagnosis of splenic lymphoma by MR imaging: value of superparamagnetic iron oxide. AJR Am J Roentgenol. 1989 Jan; 152(1):175-80.
    View in: PubMed
    Score: 0.006
  95. Primary liver tumors: diagnosis by MR imaging. AJR Am J Roentgenol. 1989 Jan; 152(1):63-72.
    View in: PubMed
    Score: 0.006
  96. MRI of hepatic lymphoma. Magn Reson Imaging. 1988 Nov-Dec; 6(6):675-81.
    View in: PubMed
    Score: 0.006
  97. Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging. Radiology. 1988 Nov; 169(2):399-403.
    View in: PubMed
    Score: 0.006
  98. Image-guided pleural biopsies: indications, technique, and results in 23 patients. Radiology. 1988 Oct; 169(1):1-4.
    View in: PubMed
    Score: 0.006
  99. Thoracic empyema: management with image-guided catheter drainage. Radiology. 1988 Oct; 169(1):5-9.
    View in: PubMed
    Score: 0.006
  100. Severe acute pancreatitis after percutaneous biopsy of the pancreas. AJR Am J Roentgenol. 1988 Sep; 151(3):493-4.
    View in: PubMed
    Score: 0.006
  101. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology. 1988 Aug; 168(2):297-301.
    View in: PubMed
    Score: 0.006
  102. Differentiation of hepatic metastases from hepatic hemangiomas and cysts by using MR imaging. AJR Am J Roentgenol. 1988 Jul; 151(1):79-84.
    View in: PubMed
    Score: 0.006
  103. Complicated pancreatic abscesses: problems in interventional management. Radiology. 1988 May; 167(2):443-6.
    View in: PubMed
    Score: 0.006
  104. Gd-DOTA: characterization of a new paramagnetic complex. Radiology. 1988 Mar; 166(3):693-8.
    View in: PubMed
    Score: 0.006
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.